D
Power Law company profile
Dynavax Technologies
Biotech & Life Sciences · Emeryville, United States · Founded 1996 · IPO 2004 Unicorn
Valuation
$1.40B
Market cap · Feb/2026
Revenue
$277M
Latest reported FY
Global footprint
Where Dynavax Technologies has talent and traffic
AI talent share
0.3%
of workforce is AI talent
(1 of 313 staff)
(1 of 313 staff)
Core AI00%
Other AI10.32%
Non-AI workforce31299.68%
Web traffic by country
7.6K
monthly visits
across markets
across markets
🇺🇸 United States51.3%
🇮🇳 India15.8%
🇩🇪 Germany11.8%
🇯🇵 Japan10.5%
🇨🇦 Canada9.2%
Patent intelligence
$32M patent portfolio · 29 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$32M
2.3% of market cap · 24.2× smaller than top peer BioNTech ($780M)
29 active patent families
Where Dynavax Technologies innovates
Molecular biologyPolynucleotideImmunomodulationsImmunologyOligonucleotide
Above peer median on Legal, Market
Quality vs same-sector peers
Dynavax Technologies on the five Patsnap quality dimensions
Dynavax Technologies in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Dynavax Technologies concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Dynavax Technologies and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Dynavax Technologies on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.